Checking Vitals
Vital Science
English - December 13, 2022 09:00 - 15 minutes - 21.9 MB - ★★★★★ - 22 ratingsLife Sciences Science Technology life sciences biotech pharma cro drug development Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: A Father’s Race Against Time
Next Episode: AviadoBio: Bold and Courageous
As we close in on the end of 2022, we’ve had the privilege to interview some amazing people who are doing great work with drug discovery.
Join Gina Mullane and Todd Poley as we reflect on some of the memorable moments and guests from this season, including an update on Amylyx Pharmaceuticals’ new ALS treatment, Chris Claussen’s discussion on the positive impacts of psychedelic drugs, and the work of Project ALS to develop a treatment for this crippling disease.
On behalf of our entire team, thank you for listening this year. We hope you’ll join us for an exciting lineup of remarkable stories set to premiere in 2023.
Show Notes:
Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS Alzheimer’s Disease Studies In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis Are Psychedelics the Next Approach to Treating Mental Health Disorders? FIRST PERSON LAUNCHES INNOVATIVE PRECISION-TARGETED COGNITIVE SUPPLEMENTS TO ACTIVATE THE FULL POTENTIAL OF HUMAN COGNITION The Hermstad Legacy: Advances in Treatments for ALS Project ALS